NGM Biopharmaceuticals, Inc. (NGM) Tops Q3 EPS by 7c

NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) reported Q3 EPS of ($0.35), $0.07 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $580 thousand versus the consensus estimate of $2.46 million.

For earnings history and earnings-related data on NGM Biopharmaceuticals, Inc. (NGM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c